Skip to content

Clinical trials

Neurocognitive Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20161
20173
20182
20202
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Universitätsklinikum Hamburg-Eppendorf2
Alkahest, Inc.1
Avraham Pharmaceuticals Ltd1
Charite University, Berlin, Germany1
Genentech, Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
University of Erlangen-Nürnberg Medical School1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders12
Dementia10
Alzheimer Disease7
Brain Diseases7
Central Nervous System Diseases6
Mental Disorders6
Nervous System Diseases6
Neurodegenerative Diseases6
Cognitive Dysfunction4
Tauopathies4

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.